SEARCH HEALTH CONDITIONS BY ALPHABETS
Campylobacter Enteritis
Medications for Campylobacter Gastroenteritis
Other names: Bacterial diarrhea; Campylobacter Enteritis; Food poisoning, campylobacter enteritis; Infectious diarrhea, campylobacter enteritis
Campylobacter enteritis is an infection in the gut brought on by Campylobacter jejuni, a kind of bacteria.
Drugs Used to Cure Campylobacter Gastroenteritis
The following listing of medications are somehow associated with, or found at the treatment of this condition.
| Drug name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| erythromycin | Rx | B | N | Y | Insert inspection | 10 | |
Generic title: erythromycin systemic Brand names: Erythrocin, Ery-Tab, EryPed, Ilosone, E.E.S.-400, E.E.S. Granules, Erythrocin Lactobionate, Eryc, PCE Dispertab...reveal all Drug course: macrolides For customers: dose, interactions, For professionals: Az Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
| Floxin | Rx | C | N | Inch inspection | 10 | ||
Generic title: ofloxacin systemic Drug course: quinolones For customers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
| Erythrocin | Rx | B | N | X | Insert inspection | 0.0 | |
Generic title: erythromycin systemic Drug course: macrolides For customers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
| Ery-Tab | Rx | B | N | X | Insert inspection | 0.0 | |
Generic title: erythromycin systemic Drug course: macrolides For customers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
| EryPed | Rx | B | N | X | Insert inspection | 0.0 | |
Generic title: erythromycin systemic Drug course: macrolides For customers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
| ofloxacin | Rx | C | N | Inch inspection | 10 | ||
Generic title: ofloxacin systemic Brand title: Floxin Drug course: quinolones For customers: dose, interactions, For professionals: Az Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
| Ilosone | Rx | B | N | Y | Insert inspection | 0.0 | |
Generic title: erythromycin systemic Drug course: macrolides For customers: dose, interactions, side effects | |||||||
| E.E.S.-400 | Rx | B | N | X | Insert inspection | 0.0 | |
Generic title: erythromycin systemic Drug course: macrolides For customers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
| E.E.S. Granules | Rx | B | N | Y | Insert inspection | 0.0 | |
Generic title: erythromycin systemic Drug course: macrolides For customers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
| Erythrocin Lactobionate | Rx | B | N | Y | Insert inspection | 0.0 | |
Generic title: erythromycin systemic Drug course: macrolides For customers: dose, interactions, side effects | |||||||
| Eryc | Rx | B | N | X | Insert inspection | 0.0 | |
Generic title: erythromycin systemic Drug course: macrolides For customers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
| minocycline | Rx | Steel | N | Insert inspection | 0.0 | ||
Generic title: minocycline systemic Brand title: Minocin for Injection Drug course: tetracyclines For customers: dose, interactions, For professionals: Az Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
| PCE Dispertab | Rx | B | N | Y | Insert inspection | 0.0 | |
Generic title: erythromycin systemic Drug course: macrolides For customers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
| Minocin for Injection | Rx | D | N | Insert inspection | 0.0 | ||
Generic title: minocycline systemic Drug course: tetracyclines For customers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | On The Counter |
| Rx/OTC | Prescription or Over The Counter |
| Away Tag | This medication might not be approved by the FDA for the treatment of this condition. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to demonstrate a risk to the embryo within the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no adequate and well-controlled studies in elderly women. |
| C | Animal research studies have demonstrated an adverse effect in the fetus and there are no adequate and well-controlled studies in humans, but possible benefits may warrant used in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may warrant used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with used in elderly women clearly outweigh potential gains. |
| N | FDA have not classified this medication. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | isn`t subject to the Controlled Substances Act. |
| Inch | Has a higher possibility of misuse. Has no currently accepted medical use in treatment in the United States. There is just a lack of accepted safety for use under medical supervision. |
| 2 | Has a higher possibility of misuse. Has a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the United States. Abuse may cause acute physical or emotional dependency. |
| 3 | Has a potential for abuse less than people in programs 1 and two. Has a currently accepted medical use in treatment in the United States. Abuse may lead to physical dependence or high psychological dependence. |
| 4 | Has a minimal potential for abuse relative to people in program 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
| 5 | Has a minimal potential for abuse relative to people in program 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
| Infection | |
|---|---|
| X | Interacts with Medication. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Janin
- S
- T
- U
- V
- W
- X
- Y
- Z
Further info
Always consult your physician to ensure the information displayed on these pages pertains to a circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
